EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunities

Ningning Ma, Jiaxin Tan, Yingfen Chen, Liu Yang, Man Li, Yong He iD

The FASEB Journal · 2024-09 · 38 (17)

DOI: 10.1096/fj.202401464r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 09.09.2024. Verfasst von Ningning Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Metabolic Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 210 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), STCSM | Natural Science Foundation of Shanghai Municipality (), Postdoctoral Fellowship Program of CPSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated diseases often refer to various diseases caused by metabolic problems such as glucose and lipid metabolism disorders. With the improvement of living standards, the increasing prevalence of metabolic diseases has become a severe public health problem, including metabolic dysfunction‐associated steatotic liver disease (MASLD), alcohol‐related liver disease (ALD), diabetes and obesity. These diseases are both independent and interdependent, with complex and diverse molecular mechanisms. Therefore, it is urgent to explore the molecular mechanisms and find effective therapeutic targets of these diseases. MicroRNAs (miRNAs) have emerged as key regulators of metabolic homoeostasis due to their multitargets and network regulatory properties within the past few decades. In this review, we discussed the latest progress in the roles of miRNA‐mediated regulatory networks in the development and progression of MASLD, ALD, diabetes and obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMetabolic DiseasesHumansAnimalsObesityDiabetes MellitusFatty Liver

Stichwörter der Autor:innen

ALDMASLDMiRNAsdiabetesobesity

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • Laboratory of Cellular Immunity, Shanghai Key Laboratory of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Yong He

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • STCSM | Natural Science Foundation of Shanghai Municipality ()
  • Postdoctoral Fellowship Program of CPSF
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Ma, N., Tan, J., Chen, Y., Yang, L., Li, M., & He, Y. (2024). MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunities. The FASEB Journal, 38(17). https://doi.org/10.1096/fj.202401464r

Vancouver

Ma N, Tan J, Chen Y, Yang L, Li M, He Y. MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunities. The FASEB Journal. 2024;38(17). doi:10.1096/fj.202401464r

BibTeX
@article{Ma2024,
  author = {Ma, Ningning and Tan, Jiaxin and Chen, Yingfen and Yang, Liu and Li, Man and He, Yong},
  title = {MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunities},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {17},
  doi = {10.1096/fj.202401464r}
}
Kostenlos starten →